Study of HX008 for the Treatment of Anaplastic Thyroid Cancer (ATC)
Clinical trial NCT04574817 · UNKNOWN
Trial details
- NCT number
- NCT04574817
- Sponsor
- Taizhou Hanzhong biomedical co. LTD
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-28
- Primary completion
- 2022-05-30
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.